{"data":{"id":4199,"citation":"Borsari C, Rageot D, Beaufils F, Bohnacker T, Keles E, Buslov I, Melone A, Sele AM, Hebeisen P, Fabbro D, Hillmann P, Wymann MP.: Preclinical Development of PQR514, a Highly Potent PI3K Inhibitor Bearing a Difluoromethyl-Pyrimidine Moiety. ACS Med Chem Lett, Volume 10 (10), 2019","title":"Preclinical Development of PQR514, a Highly Potent PI3K Inhibitor Bearing a Difluoromethyl-Pyrimidine Moiety.","doi":"10.1021\/acsmedchemlett.9b00333","doi_url":"https:\/\/doi.org\/10.1021\/acsmedchemlett.9b00333","pmid":"31620236","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31620236\/","year":2019,"journal":"ACS Med Chem Lett","volume":"10","issue":"10","page":"1473-1479","authors":[{"first_name":"Beaufils F","last_name":null,"full_name":null},{"first_name":"Bohnacker T","last_name":null,"full_name":null},{"first_name":"Borsari C","last_name":null,"full_name":null},{"first_name":"Buslov I","last_name":null,"full_name":null},{"first_name":"Fabbro D","last_name":null,"full_name":null},{"first_name":"Hebeisen P","last_name":null,"full_name":null},{"first_name":"Hillmann P","last_name":null,"full_name":null},{"first_name":"Keles E","last_name":null,"full_name":null},{"first_name":"Melone A","last_name":null,"full_name":null},{"first_name":"Rageot D","last_name":null,"full_name":null},{"first_name":"Sele AM","last_name":null,"full_name":null},{"first_name":"Wymann MP.","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/4199","landing_page":"https:\/\/molmedb.upol.cz\/publication\/4199","created_at":"2024-05-24T08:49:14.000000Z","updated_at":null}}